GENE 0.8 (-27.93%)
SE0000661613• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. GENE

Genetic Technologies (GENE) Competitor Comparison

We are evaluating the key criteria listed to compare Genetic Technologies (GENE) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 57

Dividend yield

0 / 9

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Linearity 5 years - GENE ranking 0 / 58

These are the competitors of Genetic Technologies in the industry Diagnostics & Research ranked by linearity 5 years
1. Inotiv NOTV
410.2
2. Co-Diagnostics CODX
80.52
3. Qiagen QGEN
71.99
4. Myriad Genetics MYGN
58.96
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. Syneos Health SYNH
24.79
7. Heska HSKA
15.42
8. DarioHealth DRIO
15.17
9. Olink Holding OLK
8.53
10. Trinity Biotech TRIB
7.04
11. NeoGenomics NEO
6.58
12. Pacific Biosciences of California PACB
6.51
13. Laboratory Corp of America Holdings LH
6.06
14. Aspira Womens Health AWH
5.9
15. Waters WAT
5.6
16. IQVIA Holdings IQV
5.49
17. Charles River Laboratories CRL
5.46
18. Fulgent Genetics FLGT
5.08
19. Quest Diagnostics DGX
5.07
20. CareDx CDNA
5.04
21. PerkinElmer PKI
4.97
22. Neogen NEOG
4.6
23. Anixa Biosciences ANIX
4.54
24. Illumina ILMN
4.09
25. Twist Bioscience TWST
3.97
26. National Research NRC
3.62
27. IDEXX Laboratories IDXX
3.55
28. Sotera Health SHC
3.54
29. Mettler-Toledo MTD
3.48
30. Exact Sciences EXAS
3.27
31. Guardant Health GH
3.22
32. Agilent Technologies A
3.02
33. Thermo Fisher Scientific TMO
2.93
34. Enzo Biochem ENZ
2.82
35. Psychemedics PMD
2.79
36. Sera Prognostics SERA
2.76
37. Danaher DHR
2.55
38. Bioventus BVS
2.31
39. Global Cord Blood CO
2.23
40. Exagen XGN
2.2
41. MaxCyte MXCT
2.18
42. MDxHealth MDXH
2.17
43. Interpace Biosciences IDXG
2.15
44. Personalis PSNL
2.14
45. Precipio PRPO
2.08
46. Biodesix BDSX
2.01
47. Neuronetics STIM
2
48. Prenetics Global PRE
1.91
49. bioAffinity Technologies BIAF
1.72
50. DexCom DXCM
1.7
51. Organovo Holdings ONVO
1.6
52. Icon ICLR
1.44
53. SeqLL SQL
1.39
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.78
56. RadNet RDNT
0.38
57. Lantheus Holdings LNTH
0.28
58. Medpace Holdings MEDP
0.25
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.